Larvol Delta - Bimekizumab-inhibited-radiographic-progression-across-baseline-subgroups-in-biologicna239ve-patients-with-active-psoriatic-arthritis-3year-results-from-a-phase-3-study-and-its-openlabel-extension

Bimzelx (bimekizumab-bkzx) - UCB

https://pagv3.virtual-meeting.org/eadv/eadvcongress2026/en-GB/pag/presentation/63934

Philipp Sewerin

Aug 6, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next